Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
194
Historia
147
Política y gobierno
74
Impuestos
68
Impuestos sobre la renta
41
Derecho fiscal
26
Derecho civil
25
Industria de la construcción
16
Condiciones económicas
15
Seguridad social
15
Derecho constitucional
13
Democracia
12
Derecho laboral
12
Condiciones sociales
11
México
11
Elecciones
10
Legislación
9
Partidos políticos
9
Regulación del comercio exterior
9
Colonias
8
Derecho administrativo
8
Educación
8
Historia constitucional
8
Impuesto sobre el valor agregado
8
Agricultura
7
Aranceles de aduana
7
Causas
7
Derecho
7
Función pública
7
Impuesto al valor agregado
7
-
59341por Hailu, Gebre-Mariam Tsegay, Hussen, Shemsu Umer, Getachew, Seifemichael, Berha, Alemseged Beyene“…CONCLUSION: Despite good response with the present immunosuppressive regimens, relapse, treatment-related complications and adverse events are major problems that require close monitoring. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59342“…Sensitivity to specific chemotherapy regimens can be derived from gene expressions. In addition, ALOX12B and SPRR1A expression was associated with the mRNA expression of insulin like growth factor 1 receptor (IGF1R), AKT serine/threonine kinase 1 (AKT1), mammalian target of rapamycin (MTOR), and eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) in HPV negative HNSCC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59343por Yu, Xingfeng, Chau, Janita Pak Chun, Huo, Lanting, Li, Xiaomei, Wang, Dan, Wu, Hongjuan, Zhang, Yulian“…However, among the few eligible structured education programs, heterogeneous intervention regimens and inconsistent findings were reported. Eligible programs for Chinese individuals with diabetes are lacking. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59344por Huang, Hung-Ya, Hsu, Chien-Wei, Lin, Guan-Chyun, Lin, Huey-Shyan, Chou, Yi-Jiun, Liou, I-Hsiu, Sun, Shu-Fen“…CONCLUSIONS: A single PRP injection combined with Artz or HYAJOINT Plus is effective and safe for 6 months in patients with knee OA. Both injection regimens are potential treatment options for knee OA. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59345por Mengistu, Samuel Tekle, Ghebremeskel, Ghirmay Ghebrekidan, Ghebrat, Hermon Berhe, Achila, Oliver Okoth, Yohannes, Nahom Asmerom, Ghebrenegus, Amon Solomon, Wendmhuney, Filmon Ghebretsadik, Yeibyo, Naod, Andegiorgish, Amanuel Kidane, Mesfin, Araia Berhane, Leake, Negassi“…CONCLUSION: Our findings underscore the importance of optimizing cART adherence, diversification of cART regimens, and interventions directed at enhancing early HIV diagnosis, prompt initiations of treatment, and improved patient-focused monitoring of treatment response.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59346por Goswami, Pulak, Adeniran, Oladapo R., K. Frantz, Shelby, Matsuoka, Lea, Du, Liping, Gandhi, Ripal T., Collins, Zachary S., Matrana, Marc R., Petroziello, Michael, Brower, Jayson S., Sze, Daniel Y., Kennedy, Andrew S., Golzarian, Jafar, Wang, Eric A., Brown, Daniel B.“…INTRODUCTION: National Comprehensive Cancer Network HCC guidelines recommend Y90 to treat BCLC-C patients only in select cases given the development of systemic regimens. We sought to identify ideal candidates for Y90 by assessing survival and toxicities in this patient group. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59347por Zhao, Bangbo, Qin, Cheng, Li, Zeru, Wang, Yuanyang, Li, Tianhao, Cao, Hongtao, Yang, Xiaoying, Li, Tianyu, Wang, Weibin“…Based on first-line chemotherapy regimens of PDAC, DEGs between resistant and sensitive cell lines were validated by qRT-PCR. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59348por Yi, Lin, Maier, Andrea B., Tao, Rongsheng, Lin, Zhigang, Vaidya, Aditi, Pendse, Sohal, Thasma, Sornaraja, Andhalkar, Niranjan, Avhad, Ganesh, Kumbhar, Vidyadhar“…The primary objective was to evaluate blood NAD concentration with dose-dependent regimens. The secondary objectives were to assess the safety and tolerability of NMN supplementation, next to the evaluation of clinical efficacy by measuring physical performance (six-minute walking test), blood biological age (Aging.Ai 3.0 calculator), Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), and subjective general health assessment [36-Item Short Form Survey Instrument (SF-36)]. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59349por Kavadichanda, Chengappa, Singh, Pratibha, Maurya, Supriya, Tota, Sneha, Kiroubagarin, Aberaame, Kounassegarane, Deepika, Anand, Swathi, Negi, Vir Singh, Aggarwal, Amita“…Thus, the present study was designed to determine the association of plasma vitamin D levels with clinical phenotype, disease variables and serology in a large, cohort of SLE from South Asia and to evaluate the short-term effect of two different dosage regimens of oral vitamin D supplementation on disease flares and plasma vitamin D levels. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59350por Kenney, H. Mark, Wood, Ronald W., Ramirez, Gabriel, Bell, Richard D., Chen, Kiana L., Schnur, Lindsay, Rahimi, Homaira, Korman, Benjamin D., Xing, Lianping, Ritchlin, Christopher T., Schwarz, Edward M., Cole, Calvin L.“…However, there are limited evidence-based and specific exercise regimens available to support engagement in such activities for RA patients. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59351por Mendlowitz, Andrew B., Bremner, Karen E., Krahn, Murray, Walker, Jennifer D., Wong, William W.L., Sander, Beate, Jones, Lyndia, Isaranuwatchai, Wanrudee, Feld, Jordan J.“…Undergoing testing for HCV RNA was more likely among people in older age categories (within 1 yr of antibody test; adjusted hazard ratio [HR] 1.30, 95% confidence interval [CI] 1.19–1.41, among people aged 41–60 yr; adjusted HR 1.47, 95% CI 1.18–1.81, among people aged > 60 yr), those living in rural areas (adjusted HR 1.20, 95% CI 1.10–1.30), those with an index date after Dec. 31, 2013 (era of treatment with direct-acting antiviral regimens) (adjusted HR 1.99, 95% CI 1.85–2.15) and those with a record of substance use or addictive disorders (> 1 yr after antibody test; adjusted HR 1.38, 95% CI 1.18–1.60). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59352“…Despite the potential therapeutic benefits of primer vaccine dosage regimens, public perceptions of COVID-19 vaccine booster dose (VBD) acceptance and hesitancy vary among various sub-group populations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59353“…No significant difference in live birth rate was observed between the different pretreatment regimens versus no pretreatment or between the different pretreatment protocols. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59354por Richardson, Gary Edward, Al-Rajabi, Raed, Uprety, Dipesh, Hamid, Anis, Williamson, Stephen K., Baranda, Joaquina, Mamdani, Hirva, Lee, Ya-Li, Nitika, Li, Li, Wang, Xingli, Dong, Xunwei“…Responses to monotherapy and combination regimens are typically incomplete and transient, prompting the exploration of novel FLT3 inhibitors in AML as well as solid tumors. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59355por Liang, Jinxiu, Hao, Wenke, Xia, Fangxiao, Zhao, Zhi, Wu, Yanhua, Yu, Feng, Hu, Wenxue, Fang, Xiaowu, Liu, Wei“…Therefore, it is crucial for clinicians to balance the risks and benefits of immunosuppressive therapy based on clinical and pathological characteristics and develop individualized treatment regimens for elderly patients with IMN.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59356por Gundogmus, Ayse Gokcen, Oguz, Ebru Gok, Guler-Cimen, Sanem, Kocyigit, Yasemin, Dogan, Ahmet Emin, Ayli, Mehmet Deniz“…On the other hand, KT recipients have different treatment requirements compared to HD patients, including adherence to complex immunosuppressive regimens and compliance with follow-up appointments. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59357por Drechsel, Katja C E, Pilon, Maxime C F, Stoutjesdijk, Francis, Meivis, Salena, Schoonmade, Linda J, Wallace, William Hamish B, van Dulmen-den Broeder, Eline, Beishuizen, Auke, Kaspers, Gertjan J L, Broer, Simone L, Veening, Margreet A“…The current level of evidence is insufficient and additional trials on the effects of HL and (current) treatment regimens on reproductive function are needed. In this review, we make a recommendation on reproductive markers that could be assessed and the timing of (repeated) measurements.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59358por Bortolussi-Courval, Émilie, Podymow, Tiina, Trinh, Emilie, Moryousef, Joseph, Hanula, R., Huon, Jean-François, Mavrakanas, Thomas, Suri, Rita, Lee, Todd C., McDonald, Emily Gibson“…LIMITATIONS: Deprescribing can be limited due to nephrologists’ time constraints, cognitive impairment of the hemodialyzed patient stemming from their illness and complex medication regimens, and lack of sufficient patient resources to learn about the medications they are taking and their potential harms. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59359por Luo, Haiying, Tan, Guili, Hu, Xiaoxia, Li, Yadi, Lei, Dingjia, Zeng, Yueying, Qin, Bo“…TRIM19 and TRIM38 have clinical significance in predicting virological response and guiding treatment regimens.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59360“…OBJECTIVES: To (a) assess real-world use of prophylaxis regimens in patients using 1 of 3 different long-acting products—rVIII-SingleChain, rFVIIIFc, or PEG-rFVIII; and (b) compare bleeding rates, dosing frequency, and factor consumption in 3 cohorts of patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto